When a promising therapy emerges from discovery, the clock starts ticking on its trajectory towards commercialization. Turn up your Development Velocity™ (DV™) and get to market faster with the DV Platform™.
Powered by the Scientific Data Engine®
Development Velocity is the speed a pharmaceutical company moves therapies from the lab, through development, and into the market.
After investing so much in discovery, don’t lose momentum by
relying on the status quo. Keep your development program on the fast track by accelerating Development Velocity.
Beyond clinical trials, drug development’s ‘business’ side is equally vital and complex. Twelve cross-functional teams (commercial, medical, HEOR, regulatory, etc.) simultaneously conduct hundreds of interdependent tasks.
Development teams still use outdated workflows, spreadsheets, manual data analytics, and countless meetings. These bottlenecks of inefficiency stall Development Velocity and slow the time-sensitive and costly journey to commercialization.
Replace manual processes with the DV Platform™, a comprehensive AI-powered cloud solution built to address pharma’s cross-functional and interdependent needs. The DV Platform helps development teams easily scale to support enterprise-wide objectives, a true competitive edge.
When legacy processes lack a holistic approach, pharma can’t scale to meet cross-functional needs, slowing the Development Velocity of a promising new therapy.
The path to accelerating drug development begins by establishing your baseline DV Index™ Score. Our proprietary formula measures critical KPIs that directly impact drug development. During the process, we identify the specific bottlenecks slowing your company’s development and outlines a comprehensive action plan to move toward Peak DV™.
Calculate your estimated DV by answering
these 10 questions.
The SciMar DV Platform redefines, yet doesn’t reinvent, the clinical development process. With deep pharma roots and experience, we built our platform from the ground up for pharma. We’re not another solution retrofitted for pharma that adds more deliverables that must be stitched together.
“For years, I’ve watched our industry tolerate antiquated processes that hinder Development Velocity. Having been hands on in the process, we understand both the extreme complexity in weaving many layers together during the development process. This knowledge fuels our mission to create a solution that accelerates drug development across functions to create better health outcomes for patients everywhere.”
“The Microsoft for Startups team is very pleased to be working with SciMar ONE as a member of our program. We are excited to see the way they are disrupting the life sciences market to dramatically reduce the costs, time, and risk of moving drugs from phase 2 to commercialization, saving lives and improving patient outcomes. We look forward to supporting them in their continued growth.”
— Sally Ann Frank, WW Lead, Health & Life Sciences Microsoft for Startups